Entering text into the input field will update the search result below

Tracking Dan Loeb's Third Point Portfolio - Q4 2022 Update

Mar. 20, 2023 8:57 AM ETSiriusPoint Ltd. (SPNT), TPNTFFTV, GB, PCG, PCGU, S, SPNT.PB, UNH, VTYX, CL, DHR, BBWI, AIG, MSFT, IFF, TJX, DD, OVV, FIS, FERG, DIS, HTZ, LH3 Comments
John Vincent profile picture
John Vincent


  • Dan Loeb's 13F portfolio value increased from $5.53B to $5.97B this quarter. The number of positions decreased from 61 to 44.
  • Third Point added American International Group, Microsoft, and International Flavors & Fragrances while dropping Cano Health, EQT Corp, Range Resources, and T-Mobile US.
  • The top three positions are at ~43% of the portfolio: PG&E, Colgate-Palmolive, and Danaher Corp.

Magnifying glass on top of financial market info


This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb's 13F stock portfolio on a quarterly basis. It is based on Third Point's regulatory 13F Form filed on 2/14/2023. Please visit

Dan Loeb - Third Point's Q4 2022 13F Report Q/Q Comparison

Dan Loeb - Third Point's Q4 2022 13F Report Q/Q Comparison (John Vincent (author))

This article was written by

John Vincent profile picture
Focused on analyzing 13F reports & building tools to help DIY investors generate absolute returns through exploiting inefficiency, volatility, and momentum.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of CANO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.